CYTO logo

Altamira Therapeutics (CYTO) Net Income

Annual Net Income

-$2.12 M
+$26.49 M+92.60%

01 December 2023

CYTO Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

N/A

01 June 2024

CYTO Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

N/A

01 June 2024

CYTO TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CYTO Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+92.6%--
3 y3 years+77.4%--
5 y5 years+81.9%--

CYTO Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+92.6%
5 y5 yearsat high+92.6%
alltimeall timeat high+93.0%

Altamira Therapeutics Net Income History

DateAnnualQuarterlyTTM
Dec 2023
-$2.12 M(-92.6%)
-
-
Dec 2022
-$28.61 M(+53.3%)
-
-
Dec 2021
-$18.66 M(+98.8%)
-
-
Dec 2020
-$9.39 M(+37.1%)
-
-
Dec 2019
-$6.84 M(-41.4%)
-
-
Dec 2018
-$11.68 M(-53.4%)
-$3.72 M(+22.6%)
-$11.68 M(-7.9%)
Sept 2018
-
-$3.04 M(-1.6%)
-$12.67 M(-19.8%)
June 2018
-
-$3.09 M(+68.6%)
-$15.80 M(-14.0%)
Mar 2018
-
-$1.83 M(-61.2%)
-$18.38 M(-26.3%)
Dec 2017
-$25.06 M(-16.7%)
-$4.72 M(-23.5%)
-$24.95 M(+3.0%)
Sept 2017
-
-$6.17 M(+8.9%)
-$24.22 M(-7.6%)
June 2017
-
-$5.66 M(-32.5%)
-$26.22 M(-10.1%)
Mar 2017
-
-$8.40 M(+110.3%)
-$29.16 M(-2.8%)
Dec 2016
-$30.10 M
-$3.99 M(-51.1%)
-$29.99 M(-3.6%)
Sept 2016
-
-$8.17 M(-5.1%)
-$31.11 M(+9.9%)
DateAnnualQuarterlyTTM
June 2016
-
-$8.61 M(-6.7%)
-$28.31 M(-10.2%)
Mar 2016
-
-$9.22 M(+80.2%)
-$31.53 M(+2.9%)
Dec 2015
-$30.05 M(+63.4%)
-$5.12 M(-4.6%)
-$30.63 M(+5.8%)
Sept 2015
-
-$5.36 M(-54.7%)
-$28.96 M(+6.7%)
June 2015
-
-$11.83 M(+42.2%)
-$27.13 M(+29.8%)
Mar 2015
-
-$8.32 M(+141.3%)
-$20.90 M(+8.9%)
Dec 2014
-$18.39 M(+8.8%)
-$3.45 M(-2.4%)
-$19.19 M(-3.8%)
Sept 2014
-
-$3.53 M(-36.9%)
-$19.94 M(-7.8%)
June 2014
-
-$5.60 M(-15.2%)
-$21.63 M(+2.2%)
Mar 2014
-
-$6.61 M(+57.3%)
-$21.17 M(+25.2%)
Dec 2013
-$16.91 M(+235.4%)
-$4.20 M(-19.6%)
-$16.91 M(+33.1%)
Sept 2013
-
-$5.22 M(+1.6%)
-$12.71 M(+69.7%)
June 2013
-
-$5.14 M(+119.0%)
-$7.49 M(+219.0%)
Mar 2013
-
-$2.35 M
-$2.35 M
Dec 2012
-$5.04 M
-
-

FAQ

  • What is Altamira Therapeutics annual net profit?
  • What is the all time high annual net income for Altamira Therapeutics?
  • What is Altamira Therapeutics annual net income year-on-year change?
  • What is the all time high quarterly net income for Altamira Therapeutics?
  • What is the all time high TTM net income for Altamira Therapeutics?

What is Altamira Therapeutics annual net profit?

The current annual net income of CYTO is -$2.12 M

What is the all time high annual net income for Altamira Therapeutics?

Altamira Therapeutics all-time high annual net profit is -$2.12 M

What is Altamira Therapeutics annual net income year-on-year change?

Over the past year, CYTO annual net profit has changed by +$26.49 M (+92.60%)

What is the all time high quarterly net income for Altamira Therapeutics?

Altamira Therapeutics all-time high quarterly net profit is -$1.83 M

What is the all time high TTM net income for Altamira Therapeutics?

Altamira Therapeutics all-time high TTM net profit is -$2.35 M